LOGICBIO THERAPEUTICS INC's ticker is LOGC and the CUSIP is 54142F102. A total of 45 filers reported holding LOGICBIO THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $9,000 | -25.0% | 33,907 | 0.0% | 0.00% | – |
| Q2 2022 | $12,000 | -47.8% | 33,907 | 0.0% | 0.00% | – |
| Q1 2022 | $23,000 | -70.5% | 33,907 | 0.0% | 0.00% | – |
| Q4 2021 | $78,000 | -49.7% | 33,907 | 0.0% | 0.00% | – |
| Q3 2021 | $155,000 | +40.9% | 33,907 | +36.7% | 0.00% | – |
| Q2 2021 | $110,000 | -93.5% | 24,807 | -89.4% | 0.00% | – |
| Q1 2021 | $1,700,000 | +3.7% | 233,539 | +8.7% | 0.00% | – |
| Q4 2020 | $1,639,000 | +14.5% | 214,758 | +36.2% | 0.00% | – |
| Q3 2020 | $1,432,000 | +7.1% | 157,665 | -0.3% | 0.00% | – |
| Q2 2020 | $1,337,000 | +112.6% | 158,085 | +24.2% | 0.00% | – |
| Q1 2020 | $629,000 | -31.5% | 127,240 | -0.2% | 0.00% | – |
| Q4 2019 | $918,000 | -28.8% | 127,448 | +6.9% | 0.00% | – |
| Q3 2019 | $1,289,000 | -17.3% | 119,273 | -0.5% | 0.00% | – |
| Q2 2019 | $1,559,000 | +130.6% | 119,925 | +75.2% | 0.00% | – |
| Q1 2019 | $676,000 | +8.2% | 68,447 | +13.9% | 0.00% | – |
| Q4 2018 | $625,000 | – | 60,118 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 8,466,783 | $19,558,000 | 0.25% |
| HARBOR CAPITAL ADVISORS, INC. | 282,578 | $653,000 | 0.24% |
| Sio Capital Management, LLC | 182,630 | $422,000 | 0.13% |
| SAMLYN CAPITAL, LLC | 1,511,417 | $3,492,000 | 0.05% |
| Eversept Partners, LP | 291,101 | $672,443 | 0.04% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 320,273 | $740,000 | 0.02% |
| PURA VIDA INVESTMENTS, LLC | 230,121 | $532,000 | 0.02% |
| Independence Bank of Kentucky | 12,875 | $30,000 | 0.01% |
| SANDERS MORRIS HARRIS LLC | 15,000 | $35,000 | 0.01% |
| Baker Brothers Advisors | 451,478 | $1,043,000 | 0.01% |